Belpointe Asset Management LLC Biogen Inc. Transaction History

Belpointe Asset Management LLC

$1.28 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $548,268 - $624,730	-2,137 Reduced 64.82%	1,160 $322,000
Q4 2022 Feb 08, 2023	SELL	$252.44 - $306.72 $50,488 - $61,344	-200 Reduced 5.72%	3,297 $913,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $11,876 - $16,376	61 Added 1.78%	3,497 $933,000
Q2 2022 Aug 02, 2022	BUY	$187.54 - $223.02 $18,003 - $21,409	96 Added 2.87%	3,436 $701,000
Q1 2022 Apr 28, 2022	SELL	$193.77 - $244.14 $56,580 - $71,288	-292 Reduced 8.04%	3,340 $703,000
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $133,680 - $171,798	-597 Reduced 14.12%	3,632 $871,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $15,281 - $19,928	54 Added 1.29%	4,229 $1.2 Million
Q2 2021 Aug 09, 2021	BUY	$259.0 - $414.71 $300,958 - $481,893	1,162 Added 38.57%	4,175 $1.45 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $268,945 - $315,085	-1,107 Reduced 26.87%	3,013 $843,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $693,186 - $1.04 Million	2,934 Added 247.39%	4,120 $1.01 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $2,912 - $3,362	-11 Reduced 1.16%	941 $298,000
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $64,868 - $74,898	245 Added 26.04%	1,186 $337,000
Q2 2020 Jul 20, 2020	BUY	$258.66 - $342.55 $2,845 - $3,768	11 Added 1.17%	952 $255,000
Q1 2020 Jul 20, 2020	BUY	$268.85 - $341.04 $22,045 - $27,965	82 Added 9.55%	941 $298,000
Q4 2019 Feb 18, 2020	BUY	$220.06 - $304.07 $20,025 - $27,670	91 Added 11.85%	859 $255,000
Q3 2019 Jan 16, 2020	SELL	$217.44 - $243.88 $3,696 - $4,145	-17 Reduced 2.17%	768 $179,000
Q2 2019 Nov 22, 2019	SELL	$219.29 - $241.72 $33,989 - $37,466	-155 Reduced 16.49%	785 $0
Q1 2019 Jun 11, 2019	BUY	$216.71 - $338.96 $25,788 - $40,336	119 Added 14.49%	940 $222,000
Q4 2018 Mar 06, 2019	SELL	$278.5 - $352.75 $361,214 - $457,516	-1,297 Reduced 61.24%	821 $247,000
Q3 2018 Nov 23, 2018	BUY	$293.51 - $383.83 $621,654 - $812,951	2,118 New	2,118 $748,000
Q1 2018 Aug 06, 2018	SELL	$260.13 - $367.91 $517,398 - $731,772	-1,989 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$307.64 - $344.58 $522,065 - $584,752	-1,697 Reduced 46.04%	1,989 $634,000
Q3 2017 Nov 16, 2017	BUY	$281.15 - $329.69 $1.04 Million - $1.22 Million	3,686	3,686 $1.15 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account